EU finds Johnson & Johnson COVID shot possibly linked to another rare clotting condition

The European Union’s drug regulator stated on Friday there’s a doable hyperlink between uncommon instances of bloods clots in deep veins with Johnson & Johnson’s COVID-19 vaccine and really useful the situation be listed as a side-effect of the shot.

The European Medicines Company additionally really useful immune thrombocytopenia (ITP), a bleeding dysfunction brought on by the physique mistakenly attacking platelets, be added as an adversarial response with an unknown frequency to the J&J vaccine product data and to AstraZeneca’s vaccine.